It is known that patients may cease participating in a longitudinal study and become lost to follow-up. The objective of this article is to present a Bayesian model to estimate the malaria transition probabilities considering individuals lost to follow-up. We consider a homogeneous population, and it is assumed that the considered period of time is small enough to avoid two or more transitions from one state of health to another. The proposed model is based on a Gibbs sampling algorithm that uses information of lost to follow-up at the end of the longitudinal study. To simulate the unknown number of individuals with positive and negative states of malaria at the end of the study and lost to follow-up, two latent variables were introduced in...
Birth-death processes track the size of a univariate population, but many biological systems involve...
Multi-state models can be successfully used for modelling complex event history data. In these model...
In longitudinal clinical trials, it is common that subjects may permanently withdraw from the study ...
It is known that patients may cease participating in a longitudinal study and become lost to follow-...
Plasmodium falciparum has a complex transmission cycle. Public health planning and research would be...
International audiencePlasmodium falciparum has a complex transmission cycle. Public health planning...
A discrete-time age-stage model is proposed for estimating the number of sequestered parasites in se...
#Plasmodium falciparum$ has a complex transmission cycle. Public health planning and research would ...
Abstract Background Malaria is a major public health problem in Malawi, however, quantifying its bur...
Abstract: Two treatment regimens for malaria are compared in their abilities to cure and combat rein...
As malaria transmission declines, it becomes increasingly important to monitor changes in malaria in...
The application of multi-state models has been a decisive factor for studies of longitudinal data, s...
In this paper, real-world data are used to estimate CDC (Center for Disease Control) stage transitio...
Malaria is still ranked among one of the world’s top killers. According to WHO report released in De...
Malaria is one of the three most dangerous infectious diseases worldwide (along with HIV/AIDS and tu...
Birth-death processes track the size of a univariate population, but many biological systems involve...
Multi-state models can be successfully used for modelling complex event history data. In these model...
In longitudinal clinical trials, it is common that subjects may permanently withdraw from the study ...
It is known that patients may cease participating in a longitudinal study and become lost to follow-...
Plasmodium falciparum has a complex transmission cycle. Public health planning and research would be...
International audiencePlasmodium falciparum has a complex transmission cycle. Public health planning...
A discrete-time age-stage model is proposed for estimating the number of sequestered parasites in se...
#Plasmodium falciparum$ has a complex transmission cycle. Public health planning and research would ...
Abstract Background Malaria is a major public health problem in Malawi, however, quantifying its bur...
Abstract: Two treatment regimens for malaria are compared in their abilities to cure and combat rein...
As malaria transmission declines, it becomes increasingly important to monitor changes in malaria in...
The application of multi-state models has been a decisive factor for studies of longitudinal data, s...
In this paper, real-world data are used to estimate CDC (Center for Disease Control) stage transitio...
Malaria is still ranked among one of the world’s top killers. According to WHO report released in De...
Malaria is one of the three most dangerous infectious diseases worldwide (along with HIV/AIDS and tu...
Birth-death processes track the size of a univariate population, but many biological systems involve...
Multi-state models can be successfully used for modelling complex event history data. In these model...
In longitudinal clinical trials, it is common that subjects may permanently withdraw from the study ...